Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Small integral membrane protein 29 (SMIM29) is a protein-coding gene located on human chromosome 6 that encodes a predicted small membrane protein of the DUF5546 family. The protein is annotated as an integral membrane component but its biological function and molecular mechanism are currently uncharacterized. There is no experimental molecular function or biological process annotation, and it is not currently known as a receptor, enzyme, transporter, or established therapeutic target. No drugs or clear clinical biomarker associations are known.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Small integral membrane protein 29 (SMIM29).